Christian Angermayer (Kyle Grillot/Bloomberg via Getty Images)
'Do the right thing': Billionaire pushes struggling biotech to return cash to investors
With a record number of biotechs now trading below cash amid a brutal public market downturn, many have sought ways to extend the cash runway …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
